Moderna on booster race: May the best data win

The booster competition is on, and new faces not present when the first Covid-19 vaccines were developed are joining in. Even so, Moderna has a card up its sleeve, according to Head of Europe Dan Staner.

by christian bundgaard, translated by daniel pedersen

Published: 16.06.22 at 09:56

Moderna’s head in Europe, Dan Staner, has noticed a rise in competitors vying for the European booster market.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

Access all locked articles
Receive our daily newsletters
Access our app

Start a free company trial today

Ambu, Coloplast and GN helped by relaxation of China's covid policy

Protests in China have led to a relaxation in Covid-19 restrictions. | Foto: Thomas Peter

The three firms, which all have production facilities in the country, appear to be benefitting from the relaxation of China’s zero-tolerance Covid-19 policy.

Sonova completes Hysound Group acquisition, strengthens presence in China

Arnd Kaldowski, CEO of Sonova | Foto: Sonova / Pr

The hearing aid giant now owns over 200 hearing clinics in China.

Extra data boosts Lundbeck's agitation case

Foto: Thomas Borberg/Politiken/Ritzau Scanpix

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.